146 related articles for article (PubMed ID: 36974534)
1. Significance of Serum Apelin Levels as a Biomarker for Gastric Cancer Diagnosis.
Hedayatizadeh-Omran A; Shekarriz R; Amjadi O; Alizadeh-Navaei R; Babamohammadi S
Asian Pac J Cancer Prev; 2023 Mar; 24(3):827-831. PubMed ID: 36974534
[TBL] [Abstract][Full Text] [Related]
2. Association between Serum Progastrin Biomarker Level and Gastric Cancer.
Amjadi O; Alizadeh-Navaei R; Rezapour M; Omrani-Nava V; Moosazadeh M; Azadeh H; Zaboli E; Ahmadi M; Hedayatizadeh-Omran A
Asian Pac J Cancer Prev; 2022 Oct; 23(10):3595-3599. PubMed ID: 36308387
[TBL] [Abstract][Full Text] [Related]
3. Tumor apelin, not serum apelin, is associated with the clinical features and prognosis of gastric cancer.
Feng M; Yao G; Yu H; Qing Y; Wang K
BMC Cancer; 2016 Oct; 16(1):794. PubMed ID: 27733135
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of resistin, adiponectin, and apelin in gastroesophageal cancer patients.
Diakowska D; Markocka-Mączka K; Szelachowski P; Grabowski K
Dis Markers; 2014; 2014():619649. PubMed ID: 25049439
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of serum miR-25 as a diagnostic and prognostic biomarker in human gastric cancer.
Kong Y; Ning L; Qiu F; Yu Q; Cao B
Cancer Biomark; 2019; 24(4):477-483. PubMed ID: 30909187
[TBL] [Abstract][Full Text] [Related]
6. Serum angiopoietin-like protein 2 as a potential biomarker for diagnosis, early recurrence and prognosis in gastric cancer patients.
Toiyama Y; Tanaka K; Kitajima T; Shimura T; Imaoka H; Mori K; Okigami M; Yasuda H; Okugawa Y; Saigusa S; Ohi M; Inoue Y; Mohri Y; Goel A; Kusunoki M
Carcinogenesis; 2015 Dec; 36(12):1474-83. PubMed ID: 26420253
[TBL] [Abstract][Full Text] [Related]
7. Soluble Fas might serve as a diagnostic tool for gastric adenocarcinoma.
Boroumand-Noughabi S; Sima HR; Ghaffarzadehgan K; Jafarzadeh M; Raziee HR; Hosseinnezhad H; Moaven O; Rajabi-Mashhadi MT; Azarian AA; Mashhadinejad M; Tavakkol-Afshari J
BMC Cancer; 2010 Jun; 10():275. PubMed ID: 20534173
[TBL] [Abstract][Full Text] [Related]
8. Gastric precancerous lesions in first degree relatives of patients with known gastric cancer: a cross-sectional prospective study in Guilan Province, north of Iran.
Mansour-Ghanaei F; Joukar F; Baghaei SM; Yousefi-Mashhoor M; Naghipour MR; Sanaei O; Naghdipour M; Shafighnia S; Atrkar-Roushan Z
Asian Pac J Cancer Prev; 2012; 13(5):1779-82. PubMed ID: 22901121
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of ANOS1 serve as a diagnostic biomarker of gastric cancer: a prospective multicenter observational study.
Kanda M; Suh YS; Park DJ; Tanaka C; Ahn SH; Kong SH; Lee HJ; Kobayashi D; Fujiwara M; Shimada H; Cho B; Murotani K; Kim HH; Yang HK; Kodera Y
Gastric Cancer; 2020 Mar; 23(2):203-211. PubMed ID: 31377880
[TBL] [Abstract][Full Text] [Related]
10. Family history of cancer and risk of gastric cancer in Iran.
Safaee A; Moghimi-Dehkordi B; Fatemi SR; Maserat E; Zali MR
Asian Pac J Cancer Prev; 2011; 12(11):3117-20. PubMed ID: 22394000
[TBL] [Abstract][Full Text] [Related]
11. Serum chemokine ligand 5 (CCL5/RANTES) level might be utilized as a predictive marker of tumor behavior and disease prognosis in patients with gastric adenocarcinoma.
Sima AR; Sima HR; Rafatpanah H; Hosseinnezhad H; Ghaffarzadehgan K; Valizadeh N; Mehrabi Bahar M; Hakimi HR; Masoom A; Noorbakhsh A; Razavi Satvati N; Raziee HR
J Gastrointest Cancer; 2014 Dec; 45(4):476-80. PubMed ID: 25301002
[TBL] [Abstract][Full Text] [Related]
12. Serum neural precursor cell-expressed, developmentally down regulated 9 (NEDD9) level may have a prognostic role in patients with gastric cancer.
Karabulut M; Alis H; Afsar CU; Karabulut S; Kocatas A; Oguz H; Aykan NF
Biomed Pharmacother; 2015 Jul; 73():140-6. PubMed ID: 26211595
[TBL] [Abstract][Full Text] [Related]
13. Apelin-13: A Promising Biomarker for Multiple Sclerosis?
Alpua M; Turkel Y; Dag E; Kisa U
Ann Indian Acad Neurol; 2018; 21(2):126-129. PubMed ID: 30122837
[TBL] [Abstract][Full Text] [Related]
14. Serum Apelin 13 Levels in Patients With Pulmonary Embolism.
Selimoglu Şen H; Kaplan I; Abakay Ö; Sezgi C; Yilmaz S; Taylan M; Abakay A; Tanrikulu AÇ
Clin Appl Thromb Hemost; 2016 Sep; 22(6):543-7. PubMed ID: 25693918
[TBL] [Abstract][Full Text] [Related]
15. SERUM CYTOKINE OF IL-2, IL-10 AND IL-12 LEVELS IN PATIENTS WITH STOMACH ADENOCARCINOMA.
Shokrzadeh M; Mohammadpour A; Hoseini V; Abediankenari S; Ghassemi-Barghi N; Tabari YS
Arq Gastroenterol; 2018; 55(4):385-389. PubMed ID: 30785523
[TBL] [Abstract][Full Text] [Related]
16. Serum Apelin-13 Levels Are Decreased Among Adolescents Diagnosed with Major Depressive Disorder.
Acikel SB; Artik A; Hosoglu E; Yerlikaya FH
Psychiatr Danub; 2022; 34(4):677-681. PubMed ID: 36548880
[TBL] [Abstract][Full Text] [Related]
17. circ-NOTCH1 acts as a sponge of miR-637 and affects the expression of its target gene Apelin to regulate gastric cancer cell growth.
Guan E; Xu X; Xue F
Biochem Cell Biol; 2020 Apr; 98(2):164-170. PubMed ID: 31276627
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA HOXA11-AS promotes gastric cancer cell proliferation and invasion
Liu Y; Zhang YM; Ma FB; Pan SR; Liu BZ
World J Gastroenterol; 2019 Jun; 25(22):2763-2775. PubMed ID: 31235999
[TBL] [Abstract][Full Text] [Related]
19. Serum Small Proline-Rich Protein 2A (SPRR2A) Is a Noninvasive Biomarker in Gastric Cancer.
Xu X; Wei S; Chen Y; Yu D; Wang X; Dong X
Dis Markers; 2020; 2020():8493796. PubMed ID: 32908616
[TBL] [Abstract][Full Text] [Related]
20. Relationship of vaspin and apelin levels with insulin resistance and atherosclerosis in metabolic syndrome.
Karbek B; Bozkurt NC; Topaloglu O; Aslan MS; Gungunes A; Cakal E; Delibasi T
Minerva Endocrinol; 2014 Jun; 39(2):99-105. PubMed ID: 24736484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
